EUROPEAN H2 HUB

EUROPEAN H2 HUB

Pharmaceutical Hydrogenation for Port Hydrogen Infrastructure in Rotterdam

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Rotterdam is developing into Europe's premier hydrogen hub, with the port authority investing in hydrogen import terminals, pipeline infrastructure, and large-scale electrolysis.

Local Brief

Rotterdam

Industry Focus

Port Hydrogen InfrastructureRefiningChemical ProcessingOffshore Wind-to-H2

0.1

Ω·cm²

350

μm

3x

Lower

Logistics

Air freight from India in 5-7 business days

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in Rotterdam

Rotterdam is developing into Europe's premier hydrogen hub, with the port authority investing in hydrogen import terminals, pipeline infrastructure, and large-scale electrolysis. The city's refinery and chemical cluster, combined with North Sea offshore wind, positions Rotterdam at the center of European hydrogen trade and production.

For Rotterdam's world-scale hydrogen ambitions, IONZERA provides a performance leap over the locally available Zirfon from neighboring Belgium. With 3x lower resistance, IONZERA improves the economics of the massive electrolysis capacity planned for the Rotterdam port area.

Port Hydrogen InfrastructureRefiningChemical ProcessingOffshore Wind-to-H2
20%

Thinner Profile

3x

Lower Resistance

TECHNICAL ADVANTAGE

IONZERA Performance for Rotterdam

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Membrane Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Frequently Asked Questions

Can I get IONZERA pharmaceutical hydrogenation membranes in Rotterdam?

Yes. G-Hexa ships IONZERA membranes to Rotterdam, Netherlands. Air freight from India in 5-7 business days

Why use IONZERA for pharmaceutical hydrogenation in Rotterdam?

IONZERA delivers 3x lower ionic resistance than Zirfon, reducing cell voltage and electricity costs for pharmaceutical hydrogenation applications. For Rotterdam's world-scale hydrogen ambitions, IONZERA provides a performance leap over the locally available Zirfon from neighboring Belgium.

How does IONZERA compare to locally sourced Zirfon for Rotterdam projects?

IONZERA delivers 3x lower area resistance (0.09-0.1 vs 0.30 ohm-cm2), is 20% thinner, and uses mesh-free architecture. These performance advantages outweigh Zirfon's geographic proximity to Rotterdam.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for Rotterdam

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples and technical support for your Rotterdam project.

Request Sample